TVGNW
Tevogen Bio Holdings Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.05
−8.91%Sep 16, 2026, 21:17 UTC
Tevogen Inc. granted CEO and board chair Ryan Saadi 8,000,000 restricted shares and CFO Kirti Desai 750,000 restricted shares, effective September 14, 2026.
Aug 26, 2026, 00:00 UTC
Tevogen Inc. elected Dr. Keow Lin Goh and Victor Sordillo as Class II directors, effective August 24, 2026.
Aug 13, 2026, 07:31 UTC
Short interest in Tevogen Bio Holdings Inc. increased by 4,063.1% to 81,430 shares as of July 31, 2026, from 1,956 shares on July 15, 2026.
Source:Jul 29, 2026, 12:00 UTC
Tevogen Bio Holdings Inc. announced it will operate under the name Tevogen Inc. following board approval.
Source:Jun 9, 2026, 19:30 UTC
Tevogen announced the formation of a healthcare services initiative to complement its existing biotechnology and artificial intelligence initiatives.
Source: